A Phase II clinical trial to evaluate the efficacy and safety of intra-arterial infusion chemotherapy for head and neck squamous cell carcinoma
Not Applicable
- Conditions
- head and neck squamous cell carcinoma
- Registration Number
- JPRN-UMIN000019865
- Lead Sponsor
- Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. History of intolerance or hypersensitivity to drugs which will be used or any excipient of the product. 2. Current pregnancy 3. Current known active infection 4. Uncontrolled diabetes 5. Severe heart disease 6. Severe pulmonary disease 7. Patients who are judged to be inappropriate for participation in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse event rate from starting treatment till 6months after end of treatment
- Secondary Outcome Measures
Name Time Method Response rate